Prenatal anxiety has been linked with altered immune function in offspring in animal studies, but the relevance for human health is unknown. We examined prenatal maternal anxiety as a predictor of adaptive immunity in infants at 2 and 6 months of age as part of a prospective longitudinal study. The humoral immune response to hepatitis B vaccine was assessed at 2 months (n = 80) and 6 months (n = 76) of age. Prenatal anxiety predicted lower hepatitis B antibody titers at 6 months of age independent of obstetric and socio-demographic covariates; the effects were limited to those infants who had not completed the 3-dose vaccine series (for transformed titer values, r = À.36, p < .05). Cell-mediated immune responses at 2 (n = 56) and 6 (n = 54) months of age were examined by ELISpot assays for interferon(IFN)-c, interleukin(IL)-2, and IL-4 responder cell frequencies to three antigens: hepatitis B surface antigen, tetanus toxoid, and phytohaemagglutinin (PHA). Prenatal maternal anxiety was associated with reduced IFN-c and increased IL-4 responder cell frequencies at 6 months of age, independent of obstetric and socio-demographic covariates. No effect of prenatal anxiety was found on adaptive immunity at 2 months of age. The findings provide the first demonstration in humans that prenatal anxiety alters adaptive immunity in the infant.
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Introduction
Several lines of empirical study and theory suggest that the prenatal environment may have lasting effects on the offspring's behavioral and biological development (Barker, 2007; Gluckman et al., 2005) . Prenatal stress is an exemplar. Experimental animal studies demonstrate that offspring of prenatally stressed mothers exhibit disturbances in behavior, stress physiology, cardiovascular function, neurological development, and immunity that persist into adulthood (Clarke and Schneider, 1993; Coe and Lubach, 2005; Diz-Chaves et al., 2012; Henry et al., 1994; Kay et al., 1998) . Because of the potential public health implications of these observations, several research programs have sought to translate these findings to human development. Data so far reported suggest that a wide range of outcomes in humans is linked with prenatal anxiety or stress (both risk phenotypes have been used in human studies), including psychiatric symptoms (Gutteling et al., 2005; O'Connor et al., 2003) , cognitive and language ability (Laplante et al., 2008 ), neurodevelopment (Buss et al., 2012 Glover et al., 2004; Obel et al., 2003) , and stress physiology (Davis et al., 2011; O'Connor et al., 2013; O'Donnell et al., in press ). The current study provides further translation of this work by assessing the link between prenatal anxiety and adaptive immunity in infants.
Animal studies suggest that prenatal stress has lasting effects on the immune system of offspring (Coe et al., 2002 (Coe et al., , 2007 Couret et al., 2009; Kay et al., 1998) . Although the kind of stress exposure and the particular index of immune function vary across investigation, results generally indicate that prenatal stress compromises immune responses in the offspring. Whether or not a similar link exists in humans is not known. Indirect support is suggested by studies demonstrating an association between prenatal maternal anxiety or other mood states with asthma (Khashan et al., 2012; Lefevre et al., 2011) and infectious diseases (Nielsen et al., 2011) in children; studies using cord blood samples report associations between lymphocyte subset distributions and mode of delivery as an index of perinatal stress (Duijts et al., 2008) , and between maternal stress and select in vitro cytokine responses (Wright et al., 2010) . The current study, the first to examine prenatal anxiety and specific immune responses in infants, extends this line 
